Biomarker-based Trial of NPC-1 for Alzheimer's Pathology

Clinical trial NCT07236190 · RECRUITING

Trial details

NCT number: NCT07236190
Sponsor: Massachusetts General Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer Disease Mild Cognitive Impairment (MCI)Subjective Cognitive Decline (SCD)

Start date: 2026-04-01
Primary completion: 2027-06-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.